Vanda Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.39 |
Market Cap |
$737.79 M |
Shares Outstanding |
52.96 M |
Public Float |
51.15 M |
Address |
2200 Pennsylvania Avenue NW Washington District of Columbia 20037 United States |
Employees | - |
Website | http://www.vandapharma.com |
Updated | 07/08/2019 |
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. It intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. |